Skip to main content
. Author manuscript; available in PMC: 2014 Apr 29.
Published in final edited form as: J Clin Apher. 2012 Feb 2;27(2):81–87. doi: 10.1002/jca.21206

Table 3.

Mobilization data for patients undergoing real-time rescue

Disease group Myeloma/Amyloid
(n=15)
Lymphoma
(n=24)
Total
(n=39)
Median # plerixafor doses* (range) 1 (1–4) 1 (1–4) 1 (1–4)
Median CD34+ cells/kg collected (range) 8.3 × 106
(2.9 – 15)
4.1 × 106
(0.05–6.8)
5.0 ×106
(0.5–15)
≥2 × 106 CD34+ cells/kg 15 (100%) 19 (79%) 34 (87%)
≥ 4 × 106 CD34+ cells /kg 13 (87%) 13 (54%) 26 (67%)
≥ 8 × 106 CD34+ cells /kg. 8 (53%) 0 8 (24%)